Johnson & Johnson’s global sales of contact lenses in the fourth quarter ended Dec. 31 grew by a reported 6.1 percent to $882 million. Sales at constant currency rates increased by 7.9 percent, with growth driven by price actions and the continued strong performance of the Acuvue Oasys 1-Day family ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.